We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+275.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$50.2M
Cap. Flow %
22.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Top Buys

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$8.43M
2
ELV icon
Elevance Health
ELV
+$5.15M
3
INTC icon
Intel
INTC
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Miscellaneous 7.53%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBIT icon
401
iShares Bitcoin Trust
IBIT
$61.8B
-44,200
Closed -$2.87M
IBKR icon
402
CALL
Interactive Brokers
IBKR
$42B
-40
Closed -$12.3K
IEF icon
403
iShares 7-10 Year Treasury Bond ETF
IEF
$42.1B
-50,000
Closed -$4.82M
ILCV icon
404
CALL
iShares Morningstar Value ETF
ILCV
$1.36B
-152
Closed -$49.4K
INCY icon
405
CALL
Incyte
INCY
$25.7B
-230
Closed -$297K
JAZZ icon
406
PUT
Jazz Pharmaceuticals
JAZZ
$16B
-115
Closed -$2.35K
KOD icon
407
PUT
Kodiak Sciences
KOD
$2.22B
-3
Closed -$145
LH icon
408
Labcorp
LH
$26.5B
-8,994
Closed -$2.58M
LLY icon
409
PUT
Eli Lilly
LLY
$1.02T
-23
Closed -$1.85K
MCK icon
410
McKesson
MCK
$106B
-772
Closed -$596K
DFTX
411
Definium Therapeutics
DFTX
$5.12B
-24,282
Closed -$286K
MREO
412
PUT
Mereo BioPharma
MREO
$39.9M
-91
Closed -$6.81K
MRNA icon
413
CALL
Moderna
MRNA
$58.1B
-249
Closed -$2.15K
MRNA icon
414
Moderna
MRNA
$58.1B
-4,583
Closed -$118K
MRNA icon
415
PUT
Moderna
MRNA
$58.1B
-230
Closed -$108K
MU icon
416
CALL
Micron Technology
MU
$1.15T
-12
Closed -$13.7K
NBIX icon
417
Neurocrine Biosciences
NBIX
$15.8B
-8,694
Closed -$1.22M
NIO icon
418
NIO
NIO
$9.52B
-206,260
Closed -$1.57M
NKTR icon
419
Nektar Therapeutics
NKTR
$2.53B
-17,270
Closed -$983K
NRG icon
420
NRG Energy
NRG
$25B
-1,520
Closed -$246K
NVAX icon
421
CALL
Novavax
NVAX
$1.69B
-399
Closed -$7.78K
NVO
422
Novo Nordisk
NVO
$206B
-5,759
Closed -$294K
NXT icon
423
Nextpower Inc. Common Stock
NXT
$12.8B
-10,000
Closed -$740K
OEF icon
424
PUT
iShares S&P 100 ETF
OEF
$20.5B
-60
Closed -$5.1K
OSBC icon
425
Old Second Bancorp
OSBC
$1.31B
-18,182
Closed -$314K

Similar funds

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $50.2M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.